Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
  • Pipeline
    • Overview
    • MT-3724
    • MT-5111
    • TAK-169
  • Clinical Trials
    • Overview
    • MT-3724 With Lenalidomide for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma Active, not recruiting
    • MT-3724 for Relapsed or Refractory DLBCL Active, not recruiting
    • MT-3724 With Gemcitabine and Oxaliplatin for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma Active, not recruiting
    • MT-5111 in HER2-positive Solid Tumors Recruiting
    • TAK-169 for Relapsed or Refractory Multiple Myeloma (RRMM) Recruiting
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Posters

Technology

Technology

  • Overview
  • Posters
2020 EHA - MT-3724 Monotherapy Poster - June 2020

2020 EHA - MT-3724 Monotherapy Poster - June 2020

2020 EHA - MT-3724 Len Poster - June 2020

2020 EHA - MT-3724 Len Poster - June 2020

2020 AACR - SLAMF7 Poster - April 2020

2020 AACR - SLAMF7 Poster - April 2020

2020 AACR - MT-6402 Poster - April 2020

2020 AACR - MT-6402 Poster - April 2020

2020 AACR - CTLA-4 Poster - April 2020

2020 AACR - CTLA-4 Poster - April 2020

2020 AACR - CD45 poster - April 2020

2020 AACR - CD45 poster - April 2020

2020 ASCO GI - MT-5111 Preclinical Poster - January 2020

2020 ASCO GI - MT-5111 Preclinical Poster - January 2020

RSS
© 2021 Molecular Templates, Inc. All Rights Reserved.
Twitter Linkedin
Privacy Policy Disclaimer Terms of Use Sitemap